EU OKs Liraglutide in Kids; Rejects Romosozumab for Osteoporosis EU OKs Liraglutide in Kids; Rejects Romosozumab for Osteoporosis
The CHMP recommended approval of the GLP-1 agonist liraglutide for type 2 diabetes in children aged 10 and older, but it recommended refusal of marketing authorization for osteoporosis agent romosozumab.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 28, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news
FDA Approves Victoza Injection for Children 10 Years and Older
Title: FDA Approves Victoza Injection for Children 10 Years and OlderCategory: Health NewsCreated: 6/18/2019 12:00:00 AMLast Editorial Review: 6/19/2019 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - June 19, 2019 Category: Endocrinology Source Type: news
FDA Approves Victoza Injection for Children 10 Years and Older with Type 2 Diabetes
TUESDAY, June 18, 2019 -- Victoza (liraglutide) injection is now approved to treat type 2 diabetes in children 10 years and older, the U.S. Food and Drug Administration announced.
Approved to treat type 2 diabetes in adults in 2010, Victoza is the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 18, 2019 Category: General Medicine Source Type: news
FDA Approves Victoza Injection for Children 10 Years and Older
TUESDAY, June 18, 2019 -- Victoza (liraglutide) injection is now approved to treat type 2 diabetes in children 10 years and older, the U.S. Food and Drug Administration announced yesterday.
Approved to treat type 2 diabetes in adults in 2010,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 18, 2019 Category: Pharmaceuticals Source Type: news
FDA OKs Liraglutide for Use in Youth With Type 2 Diabetes FDA OKs Liraglutide for Use in Youth With Type 2 Diabetes
Liraglutide is the first noninsulin agent approved to treat pediatric type 2 diabetes in nearly 20 years; approval comes at a time when doctors are increasingly concerned about type 2 diabetes in kids.FDA Approvals (Source: Medscape Pediatrics Headlines)
Source: Medscape Pediatrics Headlines - June 18, 2019 Category: Pediatrics Tags: Diabetes & Endocrinology News Alert Source Type: news
FDA Approves Victoza (liraglutide) for the Treatment of Pediatric Patients 10 Years or Older with Type 2 Diabetes
June 17, 2019 -- The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes. Victoza is the first non-insulin drug approved to treat type 2 diabetes... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 17, 2019 Category: Drugs & Pharmacology Source Type: news
ADA: Combo Injectable Controls Blood Glucose Longer in T2DM
FRIDAY, June 14, 2019 -- Compared with insulin glargine, initial injectable therapy with a combination of insulin degludec and liraglutide aids achievement of blood glucose goals for a longer period of time in patients with uncontrolled type 2... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 14, 2019 Category: Pharmaceuticals Source Type: news
Xultophy (insulin degludec and liraglutide injection)
Title: Xultophy (insulin degludec and liraglutide injection)Category: MedicationsCreated: 6/12/2019 12:00:00 AMLast Editorial Review: 6/12/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 12, 2019 Category: Drugs & Pharmacology Source Type: news
Little Difference With Oral Semaglutide vs Liraglutide in Diabetes Little Difference With Oral Semaglutide vs Liraglutide in Diabetes
PIONEER 4 trial shows noninferiority of oral semaglutide to liraglutide for HbA1c lowering, while PIONEER 7 shows superior glycemic control and weight loss compared with the DPP-4 inhibitor sitagliptin.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - June 11, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Liraglutide Preserves Beta-Cell Function in New Type 1 Diabetes Liraglutide Preserves Beta-Cell Function in New Type 1 Diabetes
Patients with newly diagnosed type 1 diabetes put on liraglutide, in addition to insulin, show greater preservation of insulin production 1 year after diagnosis in an intriguing, although small, study.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - June 9, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Combination medication helps patients with type 2 diabetes maintain blood sugar goals
(Brigham and Women's Hospital) Through a randomized, multicenter clinical trial, investigators studied blood glucose results for patients assigned to either take insulin (insulin glargine, IGlar U100) or insulin degludec plus liraglutide (IDegLira), a combination of both insulin and an additional medication to help with blood sugar control. The global study team found that participants who received IDegLira were better able to achieve blood glucose goals and remain at that goal longer compared to those assigned to receive IGlar. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 9, 2019 Category: International Medicine & Public Health Source Type: news
Newer Diabetes Drug Liraglutide Shows Promise in Kids, Teens
TUESDAY, April 30, 2019 -- A type 2 diabetes drug for adults also controls blood sugar levels in children and teens with the disease, researchers report.
Type 2 diabetes is on the rise among children and teens, but they have fewer treatment choices... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 30, 2019 Category: General Medicine Source Type: news
Newer Diabetes Drug, Liraglutide (Victoza), Shows Promise in Kids, Teens
TUESDAY, April 30, 2019 -- A type 2 diabetes drug for adults also controls blood sugar levels in children and teens with the disease, researchers report.
Type 2 diabetes is on the rise among children and teens, but they have fewer treatment choices... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 30, 2019 Category: General Medicine Source Type: news
Liraglutide Added to Metformin Effective for Type 2 Diabetes
MONDAY, April 29, 2019 -- The addition of liraglutide to metformin is effective and safe for children and adolescents with type 2 diabetes, according to a study published online April 28 in the New England Journal of Medicine to coincide with the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 29, 2019 Category: Pharmaceuticals Source Type: news
Drug treats Type 2 diabetes in children, team announces
(University of Texas Health Science Center at San Antonio) Jane Lynch, M.D., FAAP, professor of pediatrics at UT Health San Antonio, said the drug liraglutide, in combination with an existing medication, metformin, showed robust effect in treating children with type 2 diabetes who were studied in the Ellipse trial. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 29, 2019 Category: International Medicine & Public Health Source Type: news
